News | February 07, 2023
Alembic Pharmaceuticals Q3 FY23 revenue up 19% to Rs. 1,509 Cr
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
Experts’ conclave to pave holistic approach to cancer management
91% of cloud leaders expect their cloud capabilities to be largely centralized within the next 2 years and 64% of cloud leaders have realized cybersecurity cost savings by migrating to cloud
The company will engage with the agency to resolve the import alert at the earliest.
Medical Tourism will boost India’s economy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
There is a great opportunity for utilizing traditional medical practices like Ayurveda in Value Based Healthcare
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
Subscribe To Our Newsletter & Stay Updated
